Quarterly Activities Report and Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Algorae executes Licence & Supply Agreement with Umedica
- Peter Mac partners with Algorae on 3rd AI validation program
- Appendix 4E and 2026 Annual Report
- Quarterly Activities Report/Appendix 4C Cashflow Statement
- Peter Mac Testing Validates AlgoraeOS v2
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals